WHO launches first investment case to save up to 30 million lives

  • Posted on: 25 September 2018
  • By: Shalini.Sharma

Pharma Admission

Pharma courses

pharma admission

pharma courses

WHO  published its first investment case, setting out the transformative impacts on global health and sustainable development that a fully-financed WHO could deliver over the next five years.

The investment case describes how WHO, working together with its Member States and partners, will help to save up to 30 million lives, add up to 100 million years of healthy living to the world’s population and add up to 4 per cent of economic growth in low and middle-income countries by 2023.

Achieving these results would require an investment of $14.1 billion from 2019 to 2023, representing a 14% increase in WHO’s base budget* over the previous five-year period. These investments would help achieve the “triple billion” targets of WHO’s General Programme of Work: 1 billion more people benefitting from universal health coverage; 1 billion more people better protected from health emergencies; and 1 billion more people enjoying better health and well-being.

The investment case shows how a stronger, more efficient, and results-oriented WHO will serve and guide governments and partners in their efforts to improve the health of their populations. It highlights new mechanisms to measure success, ensuring a strict model of accountability, and sets ambitious targets for savings and efficiencies.

The document highlights the vital work WHO does in providing up-to-date, evidence-based health guidance to support countries in improving the health of their population. The investment case also emphasizes WHO’s focus on equity, gender and rights-based approaches that aim to close gaps in health service coverage and empower individuals and communities to ensure no one is left behind.

The investment case outlines WHO’s critical role as a partner, convener, and driving force in coordinating efforts across the global health arena.

<< Back to Pharma News

Subscribe to PharmaTutor News Alerts by Email


Latest News